Improving patient outcomes following glaucoma surgery: state of the art and future perspectives

Tine Van Bergen1, Sarah Van de Velde1, Evelien Vandewalle2

  • 1Laboratory of Ophthalmology, KU Leuven, Belgium.

Insights

Glaucoma filtration surgery is effective but often fails due to scarring. New strategies targeting growth factors show promise, but combined therapies and extended drug delivery are needed for better surgical outcomes.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Wound Healing Biology

Background:

  • Filtration surgery is the most effective treatment for lowering intraocular pressure in glaucoma.
  • Surgical failure commonly occurs due to excessive scar formation, leading to the closure of the constructed filtration channel.
  • Current adjunctive treatments like mitomycin C and 5-fluorouracil improve outcomes but pose risks of vision-threatening complications.

Purpose of the Study:

  • To review current and emerging strategies for preventing filtration failure after glaucoma surgery.
  • To highlight the potential of novel therapeutic targets and approaches to enhance surgical success rates.
  • To emphasize the need for combined therapies and advanced drug delivery systems.

Main Methods:

  • Review of existing literature on glaucoma filtration surgery and wound healing.
  • Analysis of the mechanisms of action for antimitotic agents and novel therapeutic targets.
  • Evaluation of the efficacy and safety profiles of different treatment strategies.

Main Results:

  • While antimitotic agents modulate wound healing, they are associated with severe complications.
  • Inhibiting growth factors such as transforming growth factor-β, vascular endothelial growth factor, and placental growth factor shows promise in preventing filtration failure.
  • Emerging strategies offer potential for improved surgical success in glaucoma patients.

Conclusions:

  • Optimizing postoperative wound healing is crucial for successful glaucoma filtration surgery.
  • Novel therapeutic targets beyond traditional antimitotic agents are essential for improving outcomes.
  • Combined therapeutic approaches and extended drug delivery systems warrant further investigation to maximize surgical success and minimize complications.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
282